Date:5/13/2010

on of the Company's intellectual property, may not be successfully prosecuted and may be subject to challenge and risks of infringement of third party rights; risks of operating in foreign jurisdictions, including operating in China with its evolving legal and economic infrastructure and the involvement of the Chinese government departments at national, state and local levels in business and economic matters; creating risks associated with various levels of political and economic conditions and other risks including but not limited to, currency exchange rates and restrictions on foreign exchange; high rates of inflation; renegotiation or nullification of existing licenses, permits and contracts; changes in taxation policies; risks associated with repatriation of profits and changing political conditions and governmental regulations; development of competing technologies in all of its business lines, and Microbix' ability to attract and retain qualified employees and management. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements.

'/>"/>

SOURCE Microbix Biosystems Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
2. Microbix Pipeline Set To Reach Milestones In 2010
3. Microbix Signs Marketing Agreement For Kinlytic(R)(Urokinase) In Growing Middle East Region
4. Microbix Biosystems Re-files Annual Results With OSC
5. Microbix Biosystems Provides a Corporate Update
6. Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility
7. Microbix Sales Grow 22% For Nine Months
8. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
9. Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half 09
10. Microbix Announces A New Technology Platform For The SST Project
11. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline